Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfusion Mismatch-Guided Extended Time Window Reperfusion Therapy for Acute Ischemic Stroke (6–24h)
ChiCTR2500103389Phase 4Not yet recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: modified Rankin Scale at 90 days. Planned start May 2025; status: not yet recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500103389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103389.